Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines
Authors:
Open Access
- 3 January 2019
- journal article
- research article
- Published by Springer Nature in BMC Veterinary Research
- Vol. 15 (1) , 6
Abstract
Actinobacillus pleuropneumoniae is the causative agent of porcine pleuropneumonia and represents a major burden to the livestock industry. Virulence can largely be attributed to the secretion of a series of haemolytic toxins, which are highly immunogenic. A. pleuropneumoniae also encodes a cytoplasmic N-glycosylation system, which involves the modification of high molecular weight adhesins with glucose residues. Central to this process is the soluble N-glycosyl transferase, ngt, which is encoded in an operon with a subsequent glycosyl transferase, agt. Plasmid-borne recombinant expression of these genes in E. coli results in the production of a glucose polymer on peptides containing the appropriate acceptor sequon, NX(S/T). However to date, there is little evidence to suggest that such a glucose polymer is formed on its target peptides in A. pleuropneumoniae. Both the toxins and glycosylation system represent potential targets for the basis of a vaccine against A. pleuropneumoniae infection. In this study, we developed cytoplasmic glycoengineering to construct glycoconjugate vaccine candidates composed of soluble toxin fragments modified by glucose. We transferred ngt and agt to the chromosome of Escherichia coli in order to generate a native-like operon for glycoengineering. A single chromosomal copy of ngt and agt resulted in the glucosylation of toxin fragments by a short glycan, rather than a polymer. A vaccine candidate that combines toxin fragment with a conserved glycan offers a novel approach to generating epitopes important for both colonisation and disease progression.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BB/M01925X/1)
This publication has 56 references indexed in Scilit:
- N-Glycosylation of Campylobacter jejuni Surface Proteins Promotes Bacterial FitnessInfection and Immunity, 2013
- Structural Insights into the Glycosyltransferase Activity of the Actinobacillus pleuropneumoniae HMW1C-like ProteinJournal of Biological Chemistry, 2011
- Cytoplasmic N-Glycosyltransferase of Actinobacillus pleuropneumoniae Is an Inverting Enzyme and Recognizes the NX(S/T) Consensus SequenceJournal of Biological Chemistry, 2011
- Silent Mischief: Bacteriophage Mu Insertions Contaminate Products of Escherichia coli Random Mutagenesis Performed Using Suicidal Transposon Delivery Plasmids Mobilized by Broad-Host-Range RP4 Conjugative MachineryJournal of Bacteriology, 2010
- Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in miceActa Veterinaria Scandinavica, 2010
- Field experience with two different vaccination strategies aiming to control infections with Actinobacillus pleuropneumoniae in a fattening pig herdActa Veterinaria Scandinavica, 2010
- The Haemophilus influenzae HMW1 Adhesin Is a Glycoprotein with an Unusual N-Linked Carbohydrate ModificationJournal of Biological Chemistry, 2008
- The Complete Genome Sequence of Actinobacillus pleuropneumoniae L20 (Serotype 5b)Journal of Bacteriology, 2008
- Protein abundance profiling of the Escherichia coli cytosolBMC Genomics, 2008
- Antibodies Specific for the High-Molecular-Weight Adhesion Proteins of NontypeableHaemophilus influenzaeAre Opsonophagocytic for both Homologous and Heterologous StrainsClinical and Vaccine Immunology, 2006